Fu Zhengqi, Wu Lixia, Chen Jiaming, Zheng Qichang, Li Ping, Zhang Li, Zhu Chuanming, Rao Zhengshou, Hu Shaobo
Department of Pathology and Pathophysiology, School of Medicine, Jianghan University Wuhan 430056, Hubei, China.
Department of Pathology, Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou 350025, China.
Int J Clin Exp Pathol. 2021 Mar 1;14(3):375-382. eCollection 2021.
The prevalence of primary hepatic mucosa-associated lymphoid tissue (MALT) lymphomas is extremely low. Here, we describe a case of this disease misdiagnosed as hepatocellular carcinoma (HCC) and review relevant literature to prevent future misdiagnoses.
a 58-year-old woman complained about abdominal pain for more than four months. About two months prior, she came to our hospital with elevated levels of HBV DNA and positive HBsAg and HBcAb. After two months of entecavir treatment, HBV DNA decreased to a normal level. She returned to the hospital with worsened abdominal pain for over a month. Magnetic resonance imaging and systemic positron emission tomography-computed tomography identified two nodes in the liver, and she was diagnosed with HCC. The patient then underwent a laparoscopic hepatectomy. Microscopic examination showed a diffuse infiltrate of small-to-medium-sized lymphocytes and lymphoepithelial lesions. Immunohistochemical staining showed that most of the lymphoid cells were strongly positive for CD20, CD79a, BCL2, IgM and weakly positive for IgD, while negative for CD3, CD10, BCL6, MUM1, CD43, CD5, cyclin D1, CD23, CD30, and PD1. The Ki-67 index of lymphoid cells was 5%. Further pathologic analysis confirmed the diagnosis of primary hepatic MALT lymphoma. The patient received antiviral treatment and recovered well with no sign of relapse for 17 months.
Primary hepatic MALT lymphoma is an uncommon disease that is difficult to diagnose and has no widely accepted treatment. Surgical resection is a good choice for both diagnosis and local therapy, and strict follow-up of the patient is essential.
原发性肝黏膜相关淋巴组织(MALT)淋巴瘤的患病率极低。在此,我们描述一例被误诊为肝细胞癌(HCC)的该疾病病例,并回顾相关文献以防止未来误诊。
一名58岁女性主诉腹痛超过四个月。大约两个月前,她因乙肝病毒脱氧核糖核酸(HBV DNA)水平升高、乙肝表面抗原(HBsAg)和乙肝核心抗体(HBcAb)阳性前来我院。恩替卡韦治疗两个月后,HBV DNA降至正常水平。她因腹痛加剧一个多月后再次入院。磁共振成像和全身正电子发射断层扫描 - 计算机断层扫描发现肝脏有两个结节,她被诊断为HCC。患者随后接受了腹腔镜肝切除术。显微镜检查显示小到中等大小淋巴细胞弥漫性浸润以及淋巴上皮病变。免疫组化染色显示大多数淋巴细胞CD20、CD79a、BCL2、IgM呈强阳性,IgD呈弱阳性,而CD3、CD10、BCL6、MUM1、CD43、CD5、细胞周期蛋白D1、CD23、CD30和PD1呈阴性。淋巴细胞的Ki-67指数为5%。进一步病理分析确诊为原发性肝MALT淋巴瘤。患者接受抗病毒治疗,恢复良好,17个月无复发迹象。
原发性肝MALT淋巴瘤是一种罕见疾病,难以诊断且尚无广泛接受的治疗方法。手术切除对于诊断和局部治疗都是一个不错的选择,对患者进行严格随访至关重要。